American Heart Journal
Volume 152, Issue 3 , Pages 420-426 , September 2006

RAte Control Efficacy in permanent atrial fibrillation: a comparison between lenient versus strict rate control in patients with and without heart failure. Background, aims, and design of RACE II

  • Isabelle C. Van Gelder, MD

      Affiliations

    • University Medical Center Groningen, University of Groningen, The Netherlands
    • Corresponding Author InformationReprint requests: Isabelle C. Van Gelder, MD, Department of Cardiology, Thoraxcenter, University Medical Center Groningen, University of Groningen, P.O. Box 30.001, 9700 RB Groningen, The Netherlands.
    • ,
  • Dirk J. Van Veldhuisen, MD

      Affiliations

    • University Medical Center Groningen, University of Groningen, The Netherlands
    • ,
  • Harry J.G.M. Crijns, MD

      Affiliations

    • University Hospital Maastricht, The Netherlands
    • ,
  • Ype S. Tuininga, MD

      Affiliations

    • WCN Deventer Hospital, The Netherlands
    • ,
  • Jan G.P. Tijssen, PhD

      Affiliations

    • Academical Medical Center, Amsterdam, The Netherlands
    • ,
  • A. Marco Alings, MD

      Affiliations

    • WCN, Amphia Hospital Breda, Breda, The Netherlands
    • ,
  • Hans A. Bosker, MD

      Affiliations

    • WCN, Rijnstate Hospital, Arnhem, The Netherlands
    • ,
  • Jan H. Cornel, MD

      Affiliations

    • WCN, Alkmaar, The Netherlands
    • ,
  • Otto Kamp, MD

      Affiliations

    • VU University Medical Center, Amsterdam, The Netherlands
    • ,
  • Nic J.G.M. Veeger, MSc

      Affiliations

    • Trial Coordination Center, University Medical Center Groningen, Groningen, The Netherlands
    • ,
  • Meint Volbeda, MD

      Affiliations

    • University Medical Center Groningen, University of Groningen, The Netherlands
    • ,
  • Michiel Rienstra, MD

      Affiliations

    • University Medical Center Groningen, University of Groningen, The Netherlands
    • ,
  • Adelita V. Ranchor, PhD

      Affiliations

    • Northern Center for Healthcare Research, Groningen, The Netherlands
    • ,
  • Elisabeth M. TenVergert, PhD

      Affiliations

    • Office for Medical Technology Assessment, University Medical Center Groningen, Groningen, The Netherlands
    • ,
  • Maarten P. Van Den Berg, MD

      Affiliations

    • University Medical Center Groningen, University of Groningen, The Netherlands

Received 4 November 2005 ,Accepted 27 February 2006.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 The study is supported by NHS (Netherlands Heart Foundation, 2003B118), ICIN (Interuniversity Cardiology Institute, The Netherlands), WCN (Working Group Cardiology, The Netherlands); AstraZeneca, Biotronik, Guidant, Medtronic, Roche, and Vitatron (all The Netherlands); and Sanofi-Aventis France.

PII: S0002-8703(06)00172-4

doi: 10.1016/j.ahj.2006.02.033

American Heart Journal
Volume 152, Issue 3 , Pages 420-426 , September 2006

Article Tools

* Image Usage & Resolution